Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression.

We studied dynamics of cell surface expression of proteolytically activated thrombin receptor (PAR-1) in human pulmonary artery endothelial cells (HPAEC). PAR-1 activation was measured by changes in cytosolic calcium concentration ([Ca2+]i) and HPAEC retraction response (determined by real-time transendothelial monolayer electrical resistance). [Ca2+]i increase in response to thrombin was abolished by preexposure to 25 nM thrombin for >60 min, indicating PAR-1 desensitization, but preexposure to 25 nM thrombin for only 30 min or to 10 nM thrombin for up to 2 h did not desensitize PAR-1. Exposure to 10 or 25 nM thrombin decreased monolayer electrical resistance 40-60%. Cells preexposed to 10 nM thrombin, but not those preexposed to 25 nM thrombin, remained responsive to thrombin 3 h later. Loss of cell retractility was coupled to decreased cell surface PAR-1 expression as determined by immunofluorescence. Cell surface PAR-1 disappeared upon short-term (30 min) thrombin exposure but reappeared within 90 min after incubation in thrombin-free medium. Exposure to 25 nM thrombin for >60 min prevented rapid cycloheximide-insensitive PAR-1 reappearance. Cycloheximide-sensitive recovery of cell surface PAR-1 expression required 18 h. Therefore, both duration and concentration of thrombin exposure regulate the time course of recovery of HPAEC surface PAR-1 expression. The results support the hypothesis that initial recovery of PAR-1 surface expression in endothelial cells results from a rapidly mobilizable PAR-1 pool, whereas delayed recovery results from de novo PAR-1 synthesis. We conclude that thrombin itself regulates endothelial cell surface PAR-1 expression and that decreased surface expression interferes with thrombin-induced endothelial cell activation responses.

[1]  A. Malik,et al.  Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[2]  M. Shuman Thrombin‐Cellular Interactions , 1986, Annals of the New York Academy of Sciences.

[3]  A. Malik,et al.  Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Hoxie,et al.  Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. , 1994, The Journal of biological chemistry.

[5]  B. Kobilka,et al.  Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. , 1994, The Journal of biological chemistry.

[6]  A. Malik,et al.  Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients. , 1992, The American journal of physiology.

[7]  G. Palade,et al.  The functional thrombin receptor is associated with the plasmalemma and a large endosomal network in cultured human umbilical vein endothelial cells. , 1995, Journal of cell science.

[8]  A. Malik,et al.  Thrombin-Mediated Increase in Vascular Endothelial Permeability , 1992, Seminars in thrombosis and hemostasis.

[9]  A. Malik,et al.  Site-specific thrombin receptor antibodies inhibit Ca2+ signaling and increased endothelial permeability. , 1997, American journal of physiology. Cell physiology.

[10]  Joe G. N. Garcia,et al.  Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers , 1992, Journal of cellular physiology.

[11]  Thiennu H. Vu,et al.  Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.

[12]  M. Caron,et al.  G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. , 1996, Canadian journal of physiology and pharmacology.

[13]  S. Coughlin,et al.  Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking , 1996, The Journal of Biological Chemistry.

[14]  M. Laposata,et al.  Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro. , 1983, Blood.

[15]  M. Caron,et al.  Modeling of sequestration and down regulation in cells containing beta2-adrenergic receptors. , 1995, Journal of receptor and signal transduction research.

[16]  J. Bodmer,et al.  Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. , 1996, The Journal of clinical investigation.

[17]  S. Coughlin Thrombin receptor function and cardiovascular disease. , 1994, Trends in cardiovascular medicine.

[18]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[19]  R. Wysolmerski,et al.  Regulation of permeabilized endothelial cell retraction by myosin phosphorylation. , 1991, American Journal of Physiology.

[20]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[21]  J. Hoxie,et al.  Internalization and recycling of activated thrombin receptors. , 1993, The Journal of biological chemistry.

[22]  F. Cohen,et al.  Mechanisms of Thrombin Receptor Agonist Specificity , 1995, The Journal of Biological Chemistry.

[23]  J. Aschner,et al.  Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet‐derived growth factor mRNA expression in cultured endothelium , 1993, Journal of cellular physiology.

[24]  B. Kobilka,et al.  Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. , 1993, The Journal of biological chemistry.

[25]  J. Hoxie,et al.  Regulation of Thrombin Receptors on Human Umbilical Vein Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[26]  M. Goligorsky,et al.  Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization , 1993, The Journal of cell biology.

[27]  L. Kjeldsen,et al.  Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. , 1994, The Biochemical journal.

[28]  C. Turck,et al.  Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface , 1994, Nature.